Table 3.
Variable | OS |
|||||
---|---|---|---|---|---|---|
Univariate |
Multivariate |
|||||
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Male sex | 1.175 | 0.544–2.538 | 0.682 | |||
Age | 1.004 | 0.974–1.036 | 0.778 | |||
Body mass index | 1.106 | 0.977–1.251 | 0.112 | |||
CCI, < 4 | 1.109 | 0.514–2.393 | 0.792 | |||
Tumor location | 0.024 | 0.289 | ||||
Right | 1.000 | 1.000 | ||||
Left | 0.346 | 0.138–0.869 | 0.583 | 0.215–1.582 | ||
Differentiation | < 0.001 | < 0.001 | ||||
WD, MD | 1.000 | 1.000 | ||||
PD, othersa | 6.924 | 2.704–17.726 | 7.904 | 2.827–22.101 | ||
Size | 0.859 | 0.703–1.048 | 0.134 | |||
T stage | 0.883 | |||||
pT4a | 1.000 | |||||
pT4b | 0.923 | 0.319–2.675 | ||||
Positive nodes | 1.203 | 0.550–2.632 | 0.643 | |||
Invasion | ||||||
Lymphatic | 1.248 | 0.374–4.156 | 0.719 | |||
Vascular | 0.787 | 0.367–1.688 | 0.539 | |||
Perineural | 1.566 | 0.714–3.436 | 0.263 | |||
CEA | 0.999 | 0.984–1.013 | 0.841 | |||
Laparoscopic | 0.421 | 0.197–0.900 | 0.026 | 0.550 | 0.253–1.196 | 0.132 |
Adjuvant chemotherapy | 0.354 | 0.146–0.857 | 0.021 | 0.344 | 0.125–0.944 | 0.038 |
HR, hazard ratio; CI, confidence interval; CCI, Charlson comorbidity index; WD, well differentiated; MD, moderate differentiated; PD, poorly differentiated; p, pathologic; CEA, carcinoembryonic antigen.
Mucinous carcinoma and signet ring cell.